+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Gene targeting and gene transfer studies of the plasminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis

Gene targeting and gene transfer studies of the plasminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis

Faseb Journal 9(10): 934-938

The plasminogen/plasmin or fibrinolytic system with its physiological triggers, tissue-type plasminogen activator, and urokinase-type plasminogen activator has been presumed to participate in normal and pathological processes of the vessel wall such as blood clot dissolution (thrombolysis), hemostasis, aneurysm formation, neovascularization, restenosis, and atherosclerosis. The implied role of the fibrinolytic system in vivo is, however, deduced from correlations between fibrinolytic activity and (patho)physiological phenomena, which does not allow establishing a cause/consequence relationship. Gene targeting and gene transfer technologies allow establishment of the in vivo role of gene products more conclusively. This article reviews briefly the findings of such studies on thrombolysis/thrombosis, hemostasis, neointima formation, atherosclerosis, and associated effects on survival.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 008721912

Download citation: RISBibTeXText

PMID: 7615162

Related references

Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system. Thrombosis and Haemostasis 74(1): 429-436, 1995

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation 96(9): 3180-3191, 1997

Role of the plasminogen/plasmin system in thrombosis, hemostasis, restenosis and atherosclerosis evaluation in transgenic animals. Trends in Cardiovascular Medicine 5(4): 117-122, 1995

Genetic analysis of the coagulation and plasminogen systems Implications in blood vessel formation, hemostasis, thrombosis, stroke, restenosis, aneurysm formation and atherosclerosis. Takada, A , Collen, D , Gaffney, P J International Congress Series; Recent progress in blood coagulation and fibrinolysis 95-105, 1997

Receptor-independent plasminogen activation by urokinase-type plasminogen activator promotes, and adenoviral PAI-1 gene transfer inhibits arterial neointima formation in mice. Fibrinolysis 10(SUPPL 3): 19, 1996

In vivo suppression of neointima formation by adenovirus-mediated gene transfer of ATFBPTI, a cell-surface directed plasmin inhibitor. Journal of Submicroscopic Cytology & Pathology 32(3): 467, 2000

Stent-induced neointima formation and plasminogen activator inhibitor-1 gene transfer in rat carotid arteries. European Heart Journal 19(ABST SUPPL ): 494, 1998

Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Circulation 99(18): 2440-2444, 1999

The effects of disruption of plasminogen gene on vascular neointima formation Analysis by the external vascular cuff-induced neointima formation mouse model. Circulation 102(18 Supplement): II 38, October 31, 2000

Specific patterns of defective HSV-1 gene transfer in the adult central nervous system: implications for gene targeting. Experimental Neurology 130(1): 127-140, 1994

Gene targeting in hemostasis. plasminogen. Frontiers in Bioscience 6: D555-D569, 2001

Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice. Circulation 103(20): 2495-2500, 2001

Impaired arterial neointima formation in mice with disruption of the plasminogen gene. Journal of Clinical Investigation 99(2): 200-208, 1997

Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1. Circulation Research 91(10): 945-952, 2002

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. Journal of Clinical Investigation 92(6): 2756-2760, 1993